Exelixis · 7 hours ago
Associate Scientific Publications Director
Exelixis is a company focused on developing innovative cancer therapies, and they are seeking an Associate Scientific Publications Director. This role is responsible for planning publication strategy, developing robust publication plans, and managing the execution of scientific presentations and publications.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Operate in accordance with all Exelixis SOPs, including the Publications SOP, and promote the adoption of working standards consistent with Good Publication Practice
Contribute to strategic, operational and tactical planning for the Exelixis Publication Plan
May write and revise abstracts, posters, case reports, and manuscripts for submission to scientific congresses or peer reviewed journals
Work with publications and writing vendors as needed
Coordinate with internal and external stakeholders; ensure execution of abstracts, posters, oral presentations and manuscripts in accordance with timelines as set in the publication plan
Use the Datavision publications portal to monitor feedback on publications
Collaborate with other members of the Medical Affairs organization (e.g. Medical Science Liaisons, Medical Information, Medical Research, etc) in support of their functional area deliverables
Attend scientific conferences to enhance therapeutic knowledge and to contribute to execution of Medical Affairs conference deliverables
Develop product and disease state expertise, keep abreast of the changing drug development environment
Other duties and responsibilities as assigned
Qualification
Required
Bachelor's level degree in related discipline and a minimum of eleven years of related experience; or
Master's level degree in related discipline and a minimum of nine years of related experience; or
Doctorate level degree (PharmD, MD, PhD) and a minimum of five years of related experience; or
Equivalent combination of education and experience
Significant experience with publication development and writing is required
Excellent organizational, time, and project management skills
Skilled medical/technical writer with attention to detail
Self-motivated, organized, problem-solving, solution-oriented, collaborative team player
Strong skills with regard to written and verbal communication of complex medical and scientific data to a variety of audiences
Strong interpersonal and collaboration competencies for interfacing with a wide range of internal and external cross-functional partners
Ability to foster relationships, build alignment, negotiate, and collaborate with internal and external stakeholders
Ability to work independently and manage multiple projects in a fast-paced and dynamic environment
Preferred
Oncology experience preferred
Experience in pharmaceutical/biotech desirable
Understanding of clinical trial design, interpretation of scientific data and communication via clinical and medical affairs channels, preferred
Benefits
401k plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
Discretionary annual bonus program
Sales-based incentive plan
Opportunity to purchase company stock
Receive long-term incentives
15 accrued vacation days in their first year
17 paid holidays including a company-wide winter shutdown in December
Up to 10 sick days throughout the calendar year
Company
Exelixis
Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
H1B Sponsorship
Exelixis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (39)
2024 (25)
2023 (25)
2022 (28)
2021 (29)
2020 (15)
Funding
Current Stage
Public CompanyTotal Funding
$514MKey Investors
Deerfield
2015-07-23Post Ipo Equity· $135M
2012-02-16Post Ipo Equity· $65M
2010-06-03Post Ipo Debt· $160M
Recent News
Investor's Business Daily
2025-12-22
2025-12-13
2025-12-12
Company data provided by crunchbase